Tenet Healthcare (NYSE:THC) Director Sells 2,500 Shares of Stock

Tenet Healthcare Corporation (NYSE:THC) Director Tammy Romo sold 2,500 shares of the business’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $260.83, for a total transaction of $652,075.00. Following the completion of the sale, the director directly owned 28,284 shares in the company, valued at approximately $7,377,315.72. This represents a 8.12% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Tammy Romo also recently made the following trade(s):

• On Thursday, August 6th, Tammy Romo sold 4,922 shares of Tenet Healthcare stock. The shares were sold at an average price of $264.15, for a total transaction of $1,300,146.30.

Tenet Healthcare Stock Down 0.7%

NYSE:THC traded down $1.80 on Monday, hitting $260.33. 889,058 shares of the company’s stock were exchanged, compared to its average volume of 1,475,405. The firm has a 50-day moving average price of $202.01 and a 200-day moving average price of $201.90. Tenet Healthcare Corporation has a 52 week low of $157.58 and a 52 week high of $265.32. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The company has a market cap of $20.96 billion, a P/E ratio of 10.04, a price-to-earnings-growth ratio of 1.00 and a beta of 1.23.

Tenet Healthcare (NYSE:THC) last released its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The business had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. During the same quarter in the previous year, the business earned $4.02 earnings per share. Tenet Healthcare’s quarterly revenue was up 6.8% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, analysts expect that Tenet Healthcare Corporation will post 21.09 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on THC shares. Barclays raised their target price on shares of Tenet Healthcare from $240.00 to $271.00 and gave the company an “overweight” rating in a research note on Friday, July 24th. Weiss Ratings cut shares of Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 2nd. Guggenheim boosted their price objective on shares of Tenet Healthcare from $242.00 to $283.00 and gave the stock a “buy” rating in a research note on Tuesday, July 28th. Royal Bank Of Canada boosted their price target on Tenet Healthcare from $236.00 to $283.00 and gave the stock an “outperform” rating in a research report on Monday, July 27th. Finally, Morgan Stanley raised their price objective on Tenet Healthcare from $254.00 to $274.00 and gave the company an “overweight” rating in a research report on Monday, July 27th. Seventeen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $272.25.

Institutional Trading of Tenet Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of THC. Triumph Capital Management acquired a new position in Tenet Healthcare in the 3rd quarter valued at about $25,000. Activest Wealth Management bought a new stake in shares of Tenet Healthcare during the fourth quarter worth approximately $26,000. Elyxium Wealth LLC acquired a new position in shares of Tenet Healthcare in the fourth quarter valued at approximately $29,000. Meeder Asset Management Inc. increased its stake in shares of Tenet Healthcare by 146.2% during the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after purchasing an additional 114 shares during the period. Finally, Trust Co. of Vermont acquired a new stake in Tenet Healthcare during the 2nd quarter worth approximately $37,000. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.